glp-1 injection NimbleRx I How to Prevent Site Discomfort from Administration UC Davis Health examines systemic

GLP-1 side effects are most intense when increasing your dose or starting the medication, and even though youre transitioning between medications, youre technically starting one for the first time

Quick Answer: GLP-1 medications show clinically meaningful average weight loss in large-scale peer-reviewed trials - approximately 14.9% for semaglutide (STEP 1) and up to 20.9% for tirzepatide (SURMOUNT-1) under trial conditions

Ozempic contains a GLP-1 receptor agonist used primarily for aiding in the treatment of type 2 diabetes, as well as aiding in weight loss

Schedule a consultation today to review your options and build a personalized weight loss plan.

Monitor your blood glucose levels

The trial exhibited a favorable safety profile with mostly mild to moderate gastrointestinal adverse events, including diarrhea (38% versus 19% in placebo), constipation (27% versus none), and appetite loss (31% versus 8%)